Sales: $210 million (estimated). Corporate sales: $714.6 million.
Key Personnel: Ron Lombardi, president and chief executive officer; Thomas Hochuli, vice president of operations; John F. Parkinson senior vice president of international; Richard Tenore, director of product development.
Major Products: Personal care, skin care, oral and OTC health care products—Chap-et, Cloverine, Debrox, Dermoplast, Efferdent, Ezo, Gly-Oxide, Kerodex, Kwellada-P, R&C, Little Remedies, New-Skin, Outgro, Oxipor, The Doctor’s oral care, DiabetAid, Caldesene, Gentle Naturals, Americane, Compound W, Kerodex, Dramamine and women’s health brands ept, Monistat and Uristat). Household care products—Comet, Cinch, Spic and Span, Chore Boy.
New Products: Compound W Freeze Off Advanced.
Comments: Fiscal 2015 was a big year for Prestige Brands, as revenues for the period ended March 31, 2015 came in at $714.6 million, an increase of 19.6%.
Revenues for the North American OTC healthcare segment increased 17.5% to $563.5 million. The firm’s Insight acquisition contributed $96.9 million to the segment overall, including a $15.4 million gain from dermatologicals, which was partially offset by declines of $7.1 million incurred by other Prestige-owned dermatological products, the company said.
Revenues for the international OTC healthcare segment increased 104.5%, primarily due to the acquisition of Hydralyte, which contributed gains via gastrointestinal, eye and ear care and cough and cold products. Hydralyte is the leading OTC brand in oral rehydration in Australia, and is now marketed through Prestige’s Care Pharmaceuticals Pty Ltd. subsidiary.
Prestige Brands’ household cleaning segment saw revenues rise 2.5% to $89.9 million.
Sales beyond the borders of North America represented 8.9% of revenues in 2015 compared to 5.4% and 2.7% in 2014 and 2013, respectively. In addition to OTC products such as Clear Eyes, Murine and Chloraseptic that are sold internationally, Prestige Brands has licensed to an international CPG company the right to use the Comet, Spic and Span and Chlorinol trademarks in the commercial/I&I business throughout the world (excluding Russia and specified Eastern European countries). Comet and Chlorinol brands have been licensed out in different deals.
In personnel moves, Matthew M. Mannelly retired last month and Ron Lombardi took over as CEO.